Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Psychopharmacology (Berl). 2013 Aug 22;231(2):333–343. doi: 10.1007/s00213-013-3245-z

Table 3.

Pharmacokinetic parameters following oral administration of 10 mg/kg ADX71441 to male C57BL/6 mice (n =24). Pharmacokinetic data shown are peak concentration (Cmax), area under the concentration time curves (AUClast and AUC0-∞), the terminal half-life value (T1/2), and time for the peak concentration (Tmax)

Dose (mg/kg) Plasma concentration ± SD at 1 h (ng/ml) Plasma concentration ± SD at 4 h (ng/ml) Plasma concentration ± SD at 24 h (ng/ml) C max ± SD (ng/ml) AUClasta ± SD (ng h/ml) AUC0–8 (ng h/ml) T 1/2 (h) T max (h)
10 (p.o.) 629±61 487±62 36.4±33 673±50 6,700±309 6,970 5.3 2
a

Tlast=24 h